| Literature DB >> 28717930 |
Georges Nemer1,2, Rémi Safi3,2, Firas Kreidieh4,2, Julnar Usta1,2, Christina Bergqvist3,2, Farah Ballout3,2, Waed Btadini3,2, Nour Hamzeh5,2, Ossama Abbas3,2, Abdul Ghani Kibbi3,2, Yutaka Shimomura2,6, Mazen Kurban7,8,9,10,11.
Abstract
Ichthyosis Follicularis, Atrichia, and Photophobia (IFAP) is a severe rare genetic disorder caused by mutations in the gene encoding the Membrane-Bound Transcription Factor Peptidase, Site 2 (MBTPS2). Olmsted syndrome is another rare genetic disease with overlapping clinical features caused by mutations in the gene encoding the Transient Receptor Potential Cation Channel, subfamily V (TRPV3). Mutations in MBTPS2 have been recently reported in Olmsted syndrome, underscoring the overlap and the confusion in separating Olmsted from IFAP syndrome. We studied a Lebanese family with IFAP syndrome both, clinically and molecularly, and investigated whether there is a cross relation between TRPV3 and MBTPS2. We identified a recurrent mutation designated p.F475S in MBTPS2 in the affected individuals. This mutation was not found in 100 control individuals from the same population. We determined that TRPV3 regulatory region is a target for MBTPS2. In addition, there was an increased cell death in the cells transfected with the mutant versus the wild-type MBTPS2. In conclusion, we identified a direct regulatory effect of MBTPS2 on TRPV3 which can partially contribute to the overlapping clinical features of IFAP and Olmsted syndromes under a common signaling pathway.Entities:
Keywords: Ichthyosis; Olmsted; Psoriasis
Mesh:
Substances:
Year: 2017 PMID: 28717930 DOI: 10.1007/s00403-017-1762-z
Source DB: PubMed Journal: Arch Dermatol Res ISSN: 0340-3696 Impact factor: 3.017